Risk Factors For Defibrillation Testing Failure In Patients With Transvenous Implantable Cardioverter Defibrillator

被引:0
|
作者
Nakano, Makoto
Aizawa, Kentaro
Hasebe, Yuhi
Morosawa, Susumu
Hayashi, Hideka
Shimokawa, Hiroaki
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A16566
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Defibrillation threshold testing: Is it necessary during implantable cardioverter-defibrillator implantation?
    Liu, Qi-Ming
    Bai, Zhong-Le
    Liu, Zhen-Jiang
    Li, Xu-Ping
    Zhou, Sheng-Hua
    MEDICAL HYPOTHESES, 2009, 72 (02) : 147 - 149
  • [22] EFFECTS OF ANTIARRHYTHMIC DRUGS ON DEFIBRILLATION THRESHOLD IN PATIENTS WITH THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    JUNG, W
    MANZ, M
    LUDERITZ, B
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (04): : 645 - 648
  • [23] Is the determination of the defibrillation threshold in patients with implantable cardioverter defibrillator still required?
    Licka, M.
    Kelemen, K.
    Bikou, O.
    Hauck, M.
    Koch, M.
    Voss, F.
    Becker, R.
    Katus, H.
    Bauer, A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 170 - 170
  • [24] Is it safe to defer defibrillation threshold testing in high risk implantable defibrillator patients?
    Tsang, B.
    Golovchiner, G.
    Dorian, P.
    Mangat, I.
    Korley, V.
    Posan, E.
    Pinter, A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 209C - 209C
  • [25] Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
    de Veld, Jolien A.
    Pepplinkhuizen, Shari
    van der Stuijt, Willeke
    Quast, Anne-Floor B. E.
    Nordkamp, Louise R. A. Olde
    Kooiman, Kirsten M.
    Wilde, Arthur A. M.
    Smeding, Lonneke
    Knops, Reinoud E.
    EUROPACE, 2023, 25 (07):
  • [26] Implantable transvenous cardioverter defibrillator leads: The dark side
    Lawton, JS
    Wood, MA
    Gilligan, DM
    Stambler, BS
    Damiano, RJ
    Ellenbogen, KA
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (09): : 1273 - 1278
  • [27] CHRONIC DEFIBRILLATION THRESHOLDS IN AN IMPLANTED TRANSVENOUS CARDIOVERTER DEFIBRILLATOR SYSTEM
    VENDITTI, FJ
    VASSOLAS, G
    MARTIN, D
    CIRCULATION, 1992, 86 (04) : 441 - 441
  • [28] CHRONIC DEFIBRILLATION THRESHOLD TESTING IN PATIENTS UNDERGOING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR GENERATOR CHANGE
    Patel, Raj
    Shahab, Ahmed
    Broman, Michael
    Aziz, Zaid
    Beaser, Andrew D.
    Upadhyay, Gaurav A.
    Kannan, Arun
    Jameria, Zenith
    Chen, Andrew
    Ozcan, Cevher
    Tung, Roderick
    Nayak, Hemal M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 538 - 538
  • [29] Defibrillation Threshold Testing Should Not Be Abandoned in Patients Receiving an Implantable Cardioverter Defibrillator for Primary Prevention.
    Tanawuttiwat, Tanyanan
    Bhan, Adarsh
    Harindhanavudhi, Tasma
    Duggal, Manoj
    Silver, Marc A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A133 - A133
  • [30] Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion?
    Russo, AM
    Sauer, W
    Gerstenfeld, EP
    Hsia, HH
    Lin, D
    Cooper, JM
    Dixit, S
    Verdino, RJ
    Nayak, HM
    Callans, DJ
    Patel, V
    Marchlinski, FE
    HEART RHYTHM, 2005, 2 (05) : 456 - 461